It was indicated that expression levels were up-regulated for SNHG3, C10orf55, C2orf27A, C5orf38, HCP5, SFTA1P, SNHG10 (for all p < 0.0001), C5orf60 (p = 0.0002), PVT1 (p = 0.0013), C6orf223 (p = 0.0135), and TMEM105 (p = 0.0357) and downregulated for MYCNOS (p = 0.0472) in tumor compared to healthy samples. This evidence concerns the gene IRX2-DT and neoplasm.